Stay updated on Flotetuzumab in PIF/ER AML Clinical Trial
Sign up to get notified when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.

Latest updates to the Flotetuzumab in PIF/ER AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedPage build updated from v3.6.2 to v3.6.3. This reflects a new release of the page rather than content changes.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page’s revision tag was updated from v3.6.0 to v3.6.2, indicating a new release of the page’s software. This update likely represents minor fixes or improvements behind the scenes rather than user-facing content changes.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page was updated to show that recruitment is closed. It also adds user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment heading, while updating the revision banner to v3.6.0.SummaryDifference0.3%

- Check40 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5. This reflects an updated page revision in the site's versioning system rather than a change to study data or content.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page now shows a newer revision version (v3.5.4) replacing the previous v3.5.3, indicating an update to the page version without altering the underlying study data.SummaryDifference0.0%

- Check83 days agoChange DetectedThis updates the ClinicalTrials.gov site’s displayed release/version from **v3.5.2** to **v3.5.3** without changing any study content.SummaryDifference0.0%

Stay in the know with updates to Flotetuzumab in PIF/ER AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.